U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07103772) titled 'Effect of Consuming a Nutraceutical Composition on Signs and Symptoms in Adult Patients With Irritable Bowel Syndrome' on Feb. 10.
Brief Summary: Irritable bowel syndrome is characterized by the presence of chronic, recurrent abdominal pain, alterations in bowel habits, and abdominal distension. The medical diagnosis is made using the Rome IV criteria. There are three IBS phenotypes: diarrhea-predominant, constipation-predominant, and mixed.
Study Start Date: March 14, 2024
Study Type: INTERVENTIONAL
Condition:
Irritable Bowel Syndrome
Irritable Bowel Syndrome With Diarrhea
Irritable Bowel Syndrome With Constipation
Irritable Bow...